Rapid micro biosystems announces inducement grants under nasdaq listing rule 5635(c)(4)

Lexington, mass., march 12, 2025 (globe newswire) -- rapid micro biosystems, inc. (nasdaq: rpid) (the “company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants (i) on march 3, 2025, of 50,000 restricted stock units (“rsus”) of the company's class a common stock (“common stock”) as a material inducement to employment of one new employee and (ii) on march 10, 2025, of non-qualified stock options to purchase an aggregate of 250,000 shares of common stock (the “options”) and 174,000 rsus as a material inducement to employment to two new employees. all such equity awards were made under the company's inducement plan, as amended (the “inducement plan”) and were approved by a majority of the independent directors of the board of directors or a duly authorized committee thereof in accordance with nasdaq listing rule 5635(c)(4). the equity awards are subject to the terms and conditions of the inducement plan, and the terms and conditions of the applicable stock option and rsu award agreements covering the grants.
NDAQ Ratings Summary
NDAQ Quant Ranking